The Anti-Kickback Statute Explained for B2B Operators

The Federal Line Most B2B Marketers Don't Know They’ve Crossed

If you sell software into healthcare, life sciences, or public sector agencies, you are likely flirting with a felony.

The Anti-Kickback Statute (AKS) is a federal criminal law that prohibits the exchange of anything of value to induce or reward referrals of business reimbursable by federal healthcare programs like Medicare or Medicaid. Most B2B operators think "kickback" means a briefcase of cash handed to a surgeon in a parking garage. It doesn't.

In the world of Healthtech and Fintech, a kickback can be as subtle as a $500 Amazon gift card sent to a Director of Revenue Cycle management in exchange for a "discovery call" that eventually leads to a contract. If that contract involves federally funded services, you are in the crosshairs.

The "One Purpose" Rule

The most dangerous part of the Anti-Kickback Statute B2B teams overlook is the "One Purpose" rule. Federal courts have consistently held that if any one purpose of a payment or gift is to induce a referral, the entire transaction is illegal.

It does not matter if the payment was also for a legitimate service. It does not matter if the price paid was "Fair Market Value" (FMV). If the underlying intent was to grease the wheels for a sale involving federal funds, the Department of Justice (DOJ) can prosecute.

For a VP of Growth at a Series C healthtech company, this means your standard "Gift for a Demo" playbook is a legal liability. If that demo lead works for a hospital system receiving federal funds, that $100 DoorDash credit is effectively a bribe under the eyes of the law.

Why "Consulting Fees" Won't Save You

A common tactic for B2B startups is to put prospective buyers on an "Advisory Board" or pay them for "Consulting."

Here is how the OIG (Office of Inspector General) sees that:

• The Sham Test: Does the advisor actually produce work? If you pay a Chief Medical Officer $2,000 for a one-hour lunch and there are no notes, no deliverables, and no follow-up, it’s a kickback.
• The Volume/Value Test: Is the advisor being paid more because they have the power to refer more business? If your "consulting fee" scales based on how many clinics the advisor manages, you’re in trouble.
• The Necessity Test: Do you actually need 50 advisors? If you have 50 prospects on your "Advisory Board" and they all just happen to be your target personas, the DOJ sees a pay-to-play scheme.

BuyerSignal solves this by enforcing a compliance-first architecture where interactions are structured as professional research, ensuring that payments are transparent, documented, and decoupled from sales "inducement."

Safe Harbors: The Only Way to Sleep

The law is broad, but the "Safe Harbors" are specific. If your arrangement fits into a Safe Harbor, it is immune from prosecution. Operating outside of them isn't necessarily illegal, but it's high-risk.

1. Personal Services and Management Contracts: To hit this, the agreement must be in writing, signed for at least one year, and the compensation must be set in advance. It cannot take into account the volume or value of any referrals.
2. Discounts: These must be clearly documented and disclosed at the time of sale. You cannot provide a "discount" in the form of a separate cash payment to a decision-maker.
3. GPO (Group Purchasing Organization) Fees: These have very specific reporting requirements and must be transparent to the participating providers.

The Cost of Getting It Wrong

The penalties are not "cost of doing business" fines. They are business-ending.

• Criminal: Fines up to $100,000 per violation and up to 10 years in prison.
• Civil: Civil Monetary Penalties (CMP) can be up to $100,000 plus three times the amount of the kickback.
• Exclusion: The "death penalty" for Healthtech. You are banned from participating in any federal healthcare program. If you are excluded, no hospital or clinic can buy your software without losing their own funding.

Contrarian View: Compliance is a Competitive Advantage

Most B2B operators view the Anti-Kickback Statute as a hurdle to clear. The smart ones view it as a moat.

When a VP of Sales at a competitor is sending illegal "referral fees" to doctors, they are building a house on sand. One whistleblower or one routine audit, and their entire book of business evaporates. By building a compliant research and feedback loop from day one, you build a brand that enterprise legal teams actually trust.

Enterprises—especially those in regulated industries—are terrified of their employees accepting "gifts" that trigger AKS investigations. When you offer a transparent, audited way to engage with their experts, you bypass the red tape that kills most deals.

BuyerSignal provides the infrastructure to engage professionals for product research without crossing the lines of the Anti-Kickback Statute. Use BuyerSignal to build a compliant, documented stream of market intelligence that keeps your legal team happy and your growth on track.